[시장보고서]세계의 더말 필러 시장(성별, 재료별, 최종사용자별, 유통채널별, 주요 지역별) : 산업 동향 및 예측(2023-2035년)

세계의 더말 필러 시장(성별, 재료별, 최종사용자별, 유통채널별, 주요 지역별) : 산업 동향 및 예측(2023-2035년)

Dermal Fillers Market, 2023-2035 - Distribution by Gender, by Material, End User, Distribution Channel and Key Geographical Regions : Industry Trends and Global Forecasts

상품코드 : 1411404

리서치사 : Roots Analysis

발행일 : 2024년 01월

페이지 정보 : 영문 234 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,799

￦ 6,996,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999

￦ 10,204,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599

￦ 15,453,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999

￦ 26,242,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

세계의 더말 필러 시장은 2023년 30억 달러로 평가되며 예측 기간(2023-2035년) 동안 9%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

시시각각 변화하는 메디컬 에스테틱의 세계에서 최신 트렌드에 대응하는 것은 개발자와 소비자 모두에게 우선순위가 되고 있습니다. 더말 필러는 히알루론산을 겔 형태로 함유한 주사 치료로, 페이셜 필러라고도 불립니다. 더말 필러는 최근 몇 년동안 얼굴 회춘, 즉각적인 안면 리프팅, 흉터 치료 및 입술 강화와 관련하여 소비자들 사이에서 가장 많이 찾는 옵션 중 하나가 되었으며, IAPS에 따르면 2022년에는 전 세계적으로 430만 건 이상의 히알루론산 더말 필러 시술이 이루어질 것으로 예상됩니다. 이는 이 시술이 최소침습적이기 때문에 성형수술을 원하는 많은 환자들에게 적합하기 때문인 것으로 보입니다. 경우에 따라 이러한 시술은 비침습적(통증이 거의 없거나 전혀 없는)일 수도 있습니다.

더말 필러는 일반적으로 히알루론산, 젖산, 칼슘 하이드록시아파타이트, 폴리메틸메타크릴산 겔로 구성됩니다. 필러는 보통 얼굴에서 콧등, 입꼬리, 볼, 입꼬리, 입꼬리 등의 부위에 피하로 주입합니다. 치료에는 마취가 필요하지 않습니다. 치료 기간은 재료에 따라 5개월에서 5년까지 다양합니다. 과학자들은 캐뉼라 기법을 사용하여 더말 필러 시장에 혁명을 일으키고 있습니다. 캐뉼라 기법은 시술의 침습성을 줄이고, 멍을 최소화하며, 필러의 정확한 배치를 가능하게 합니다. 기술의 발전으로 차세대 필러의 개발도 가능해졌습니다. 이러한 필러는 더 나은 가교 특성을 가지고 있어 더 오래 지속되는 결과를 제공합니다. 진피 필러 치료에 대한 수요가 증가하고 매년 진피 필러 치료가 필요한 환자가 증가함에 따라 진피 필러 주입 시장은 예측 기간 동안 성장할 것으로 예상됩니다.

세계의 더말 필러(Skin Filler) 시장에 대해 분석했으며, 제품 개요와 시장의 기본 구조 및 최신 상황, 주요 시장 성장 촉진요인 및 억제요인, 전체적인 시장 규모 동향 전망, 부문별/지역별(5개 지역) 상세 동향, 최근의 주요 사업 제휴 및 자본 거래 동향(투자, M&A 등), 현재 경쟁 구도, 주요 기업 프로파일 등을 조사하였습니다.

주요 시장 구분

성별

남성
여성

재료별

히알루론산 필러
비히알루론산 필러

최종사용자별

병원
클리닉/메디컬 스파, 피부과/미용 센터
기타 최종 사용자

판매 채널별

직접 판매
간접 판매

주요 지역별로

북미(미국, 캐나다, 멕시코)
유럽(영국, 독일, 프랑스, 이탈리아, 스페인, 기타)
아시아태평양(중국, 한국, 일본, 인도)
중동/북아프리카(터키, 이란, 기타)
중남미(브라질, 아르헨티나, 기타)

주요 시장 진출기업

Allergan Aesthetics
Alma Lasers
Biotechitalia
Bison Medical
Koru Pharma
MedicalZone

Merz Pharma
Mesoestetic
MesoTech
NeoGenesis
Sinclair Pharma
Xcelene

영문목차

The dermal fillers market is valued at USD 3 billion in 2023 growing at a CAGR of 9% during the forecast period 2023-2035.

In the ever-changing world of medical aesthetics, staying up to date with the latest trends has become a priority for both the developers and the consumers. Dermal fillers are injectable treatments that contain hyaluronic acids in the form of gel-like substances. They are also called facial fillers. In recent years, dermal fillers have become one of the most sought-after options among consumers when it comes to facial rejuvenation, instant facial lift, scar treatment, and lip enhancement. According to IAPS, in 2022, more than 4.3 million Hyaluronic acid Dermal Filler procedures were performed worldwide. This is largely due to the fact that the procedure is minimally invasive, making it suitable for a large number of patients seeking cosmetic procedures. In some cases, these procedures can be non-invasive, meaning they involve minimal or no pain.

Dermal fillers are generally made up of hyaluronic acids, lactic acids, calcium hydroxyapatite and polymethyl methacrylic acid gels. Dermal fillers are usually injected under the skin in the following areas of the face: nasolabial fold, marionette line, cheeks, oral commissures, etc. Treatment does not require anesthesia. The duration of the treatment can range from 5 months up to 5 years depending on the material used. Scientists are revolutionizing the field of Dermal Fillers market by using cannula technique. Cannula technique involves the use of a blunt tip cannula despite the presence of a needle for the injection of fillers. This approach reduces the invasive nature of the procedure, minimizes bruising, and allows for precise placement of fillers. Technological advances have also enabled the development of next generation fillers. These fillers have better cross-linking characteristics and provide longer lasting results. With the growing demand and increasing number of patients requiring dermal filler treatments every year, the dermal filler injection market is expected to grow over the forecast period.

Key Market Segments

Gender

Male
Female

Material

Hyaluronic Fillers
Non-Hyaluronic Acid Fillers

End User

Hospitals
Clincs / Med Spas and Dermatology / Cosmetology Centers
Other end users

Distribution Channel

Direct Distribution
Indirect Distribution

Key Geographical Regions

North America (U.S., Canada, Mexico)
Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
Asia-Pacific (China, South Korea, Japan, India)
Middle East and North Africa (Turkey, Iran, Rest of the Middle East and North Africa)
Latin America (Brazil, Argentina, Rest of the Latin America)

Research Coverage:

The report studies the dermal fillers market based on gender, material, end user, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides an overview of medical aesthetics, including dermal fillers, benefits and drawbacks of these procedures. Further, the chapter also covers the new technologies applied in this field.

Comprehensive analysis of the current landscape of dermal filler developers considering parameters such as establishment year, company size, headquarters, application area and end user

In-depth profiles of companies offering dermal filler procedures products and / or devices, focusing on company overviews, financial information (where available), offered dermal filler procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of dermal filler company, considering various parameters.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in medical aesthetics dermal fillers companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report

The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.

Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.

The report provides stakeholders with a pulse on the dermal fillers market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

Allergan Aesthetics
Alma Lasers
Biotechitalia
Bison Medical
Koru Pharma
MedicalZone

Merz Pharma
Mesoestetic
MesoTech
NeoGenesis
Sinclair Pharma
Xcelene

1. PREFACE

1.1. Introduction
1.2. Project Objectives
1.3. Scope of the Report
1.4. Inclusions and Exclusions
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
- 2.7.1. Demographics
- 2.7.2. Economic Factors
- 2.7.3. Government Regulations
- 2.7.4. Supply Chain
- 2.7.5. COVID Impact / Related Factors
- 2.7.6. Market Access
- 2.7.7. Healthcare Policies
- 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview
3.2. Market Dynamics
- 3.2.1. Time Period
  - 3.2.1.1. Historical Trends
  - 3.2.1.2. Current and Forecasted Estimates
- 3.2.2. Currency Coverage
  - 3.2.2.1. Overview of Major Currencies Affecting the Market
  - 3.2.2.2. Impact of Currency Fluctuations on the Industry
- 3.2.3. Foreign Exchange Impact
  - 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
  - 3.2.3.2. Strategies for Mitigating Foreign Exchange Ris
- 3.2.4. Recession
  - 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
  - 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
- 3.2.5. Inflation
  - 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
  - 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview
5.2. Concept of Medical Aesthetics
5.3. Evolution of Medical Aesthetics
5.4. Dermal Fillers
5.5. Advantages of Dermal Fillers
5.6. Side Effects of Dermal Fillers
5.7. Key Growth Drivers of Medical Aesthetics
5.8. Emerging Technologies in Medical Aesthetics
- 5.8.1. Virtual Reality in Medical Aesthetics
- 5.8.2. Augmented Reality in Medical Aesthetics
- 5.8.3. Artificial Intelligence in Medical Aesthetics
- 5.8.4. Telemedicine in Medical Aesthetics
5.9. Key Challenges of Medical Aesthetics
5.10. Future Perspectives

6. MARKET LANDSCAPE

6.1. Chapter Overview
6.2. Dermal Fillers: Overall Market Landscape
- 6.2.1. Analysis by Year of Establishment
- 6.2.2. Analysis by Company Size
- 6.2.3. Analysis by Location of Headquarters (Region)
- 6.2.4. Analysis by Location of Headquarters (Country)
- 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
- 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
- 6.2.7. Analysis by Application Area
- 6.2.8. Analysis by End-user

7. COMPANY PROFILES

7.1. Chapter Overview
7.2. Allergan Aesthetics
- 7.2.1. Company Overview
- 7.2.2. Financial Information
- 7.2.3. Medical Aesthetics Portfolio
- 7.2.4. Recent Developments and Future Outlook
7.3. Croma Pharma
- 7.3.1. Company Overview
- 7.3.2. Financial Information
- 7.3.3. Medical Aesthetics Portfolio
- 7.3.4. Recent Developments and Future Outlook
7.4. Galderma
- 7.4.1. Company Overview
- 7.4.2. Financial Information
- 7.4.3. Medical Aesthetics Portfolio
- 7.4.4. Recent Developments and Future Outlook
7.5. IBSA
- 7.5.1. Company Overview
- 7.5.2. Medical Aesthetics Portfolio
- 7.5.3. Recent Developments and Future Outlook
7.6. Sinclair Pharma
- 7.6.1. Company Overview
- 7.6.2. Medical Aesthetics Portfolio
- 7.6.3. Recent Developments and Future Outlook

8. COMPANY COMPETITIVENESS ANALYSIS

8.1. Chapter Overview
8.2. Key Assumptions and Parameters
8.3. Methodology
8.4. Medical Aesthetics: Company Competitiveness Analysis
- 8.4.1. Companies based in North America
- 8.4.2. Companies based in Europe
- 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

9.1. Chapter Overview
9.2. Partnership Models
9.3. Dermal Fillers: Partnerships and Collaborations
- 9.3.1. Analysis by Year of Partnership
- 9.3.2. Analysis by Type of Partnership
- 9.3.3. Analysis by Year and Type of Partnership
- 9.3.4. Analysis by Focus Area
- 9.3.5. Most Active Players: Analysis by Number of Partnerships
9.4. Analysis by Geography
- 9.4.1. Local and International Agreements
- 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

10.1. Chapter Overview
10.2. Funding Models
10.3. Dermal Fillers: Funding and Investments
- 10.3.1. Analysis by Year of Funding
- 10.3.2. Analysis by Amount Invested
- 10.3.3. Analysis by Type of Funding
- 10.3.4. Analysis by Year and Type of Funding
- 10.3.5. Analysis by Type of Funding and Amount Invested
- 10.3.6. Analysis by Geography
- 10.3.7. Most Active Players
  - 10.3.7.1. Analysis by Number of Funding Instances
  - 10.3.7.2. Analysis by Amount Raised
- 10.3.9. Analysis by Company Size and Amount Invested
- 10.3.10. Leading Investors: Analysis by Number of Funding Instances
10.4. Concluding Remarks

11. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion

12. GLOBAL DERMAL FILLERS MARKET

12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Dermal Fillers Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 12.3.1. Scenario Analysis
  - 12.3.1.1. Conservative Scenario Analysis
  - 12.3.1.2. Optimistic Scenario Analysis
12.4. Key Market Segmentations
12.5. Dynamic Dashboards

13. DERMAL FILLERS MARKET, BY END-USER

13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Dermal Fillers Market: Distribution by End-user, 2018, 2023 and 2035
- 13.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

13.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

13.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

13.4. Data Triangulation and Validation

14. DERMAL FILLERS MARKET, BY GENDER

14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Dermal Fillers Market: Distribution by Gender, 2018, 2023 and 2035
- 14.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 14.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4. Data Triangulation and Validation

15. DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL

15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Dermal Fillers Market, by Distribution Channel, 2015, 2023 and 2035
- 15.3.1. Direct Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
- 15.3.2. Indirect Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
15.4. Data Triangulation and Validation

16. DERMAL FILLERS MARKET, BY KEY GEOGRAPHICAL REGION

16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Dermal Fillers Market: Distribution by Key Geographical Regions, 2016, 2023 and 2035
- 16.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.1.1. US: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.1.2. Canada: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.1.3. Mexico: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 16.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.2.1. UK: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.2.2. Germany: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.2.3. France: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.2.4. Italy: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.2.5. Spain: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.2.5. Rest of the Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 16.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.3.1. China: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.3.2. South Korea Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.3.3. Japan: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.3.4. India: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 16.3.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.4.1. Turkey: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.4.2. Iran: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 16.3.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.5.1. Brazil: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.5.2. Argentina: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  - 16.3.5.3. Rest of the Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Data Triangulation and Validation

17. DERMAL FILLERS PRODUCT MARKET

17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Global Dermal Fillers Product Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Dermal Fillers Products Market, by Key Geographical Regions, 2018, 2023 and 2035
- 17.4.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 17.4.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 17.4.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 17.4.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 17.4.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Data Triangulation and Validation

한글목차

주요 시장 구분

성별

재료별

최종사용자별

판매 채널별

주요 지역별로

주요 시장 진출기업

목차

제1장 서론

제2장 조사 방법

제3장 경기 동향과 기타 프로젝트 특유의 고려사항

제4장 주요 요약

제5장 서론

제6장 시장 구도

제7장 기업 개요

제8장 기업 경쟁력 분석

제9장 파트너십과 협업

제10장 자금조달과 투자

제11장 시장에 대한 영향 분석 : 촉진요인 및 억제요인, 기회, 과제

제12장 세계의 더말 필러 시장

제13장 더말 필러 시장, 최종사용자별

제14장 더말 필러 시장 : 성별

제15장 더말 필러 시장, 유통 채널별

제16장 더말 필러 시장 : 주요 지역별

제17장 더말 필러 제품 시장

제18장 주요 인사이트

제19장 결론

제20장 부록 1 : 표 형식 데이터

제21장 부록 2 : 기업 및 조직 리스트